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OBJECTIVE: The objective of this study was to perform a nutritional assessment of acute kidney injury patients
and to identify the relationship between nutritional markers and outcomes.
METHOD: This was a prospective and observational study. Patients who were hospitalized at the Hospital of
Botucatu School of Medicine were evaluated between January 2009 and December 2011. We evaluated a total
of 133 patients with a clinical diagnosis of acute kidney injury and a clinical presentation suggestive of acute
tubular necrosis. We explored the associations between clinical, laboratory and nutritional markers and in-
hospital mortality. Multivariable logistic regression was used to adjust for confounding and selection bias.
RESULTS: Non-survivor patients were older (67¡14 vs. 59¡16 years) and exhibited a higher prevalence of sepsis
(57.1 vs. 21.4%) and higher Acute Tubular Necrosis-Individual Severity Scores (0.60¡0.22 vs. 0.41¡0.21) than
did survivor patients. Based on the multivariable analysis, laboratorial parameters such as blood urea nitrogen
and C-reactive protein were associated with a higher risk of death (OR: 1.013, p=0.0052; OR: 1.050, p=0.01,
respectively), and nutritional parameters such as low calorie intake, higher levels of edema, lower resistance
based on bioelectrical impedance analysis and a more negative nitrogen balance were significantly associated
with a higher risk of death (OR: 0.950, p=0.01; OR: 1.138, p=0.03; OR: 0.995, p=0.03; OR: 0.934, p=0.04,
respectively).
CONCLUSIONS: In acute kidney injury patients, a nutritional assessment seems to identify nutritional markers
that are associated with outcome. In this study, a low caloric intake, higher C-reactive protein levels, the
presence of edema, a lower resistance measured during a bioelectrical impedance analysis and a lower nitrogen
balance were significantly associated with risk of death in acute kidney injury patients.
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& INTRODUCTION
Acute kidney injury (AKI) is a common clinical complica-
tion, particularly in intensive care units (ICUs). It affects
approximately 5% of patients requiring renal replacement
therapy (RRT), with mortality rates as high as approxi-
mately 60% (1). Clinical conditions such as age, mechanical
ventilation requirement, vasopressors and septic shock are
conditions that significantly contribute to an increased in-
hospital mortality rate in these patients (2).
Nutritional and metabolic factors, such as hypercatabo-
lism and pro-oxidative and proinflammatory states also
predispose these patients to higher mortality rates (3).
Although it is known that AKI affects the metabolism of
all macronutrients and causes important consequences for
the nutritional status and prognosis of AKI patients, a clear
understanding of the changes and their associations with
important clinical prognostic factors remains elusive.
Laboratory parameters such as prealbumin, albumin, IGF-
1 and cholesterol are described as risk factors for increased
mortality (4-7). The presence of pre-existing severe malnutri-
tion is also associated with a higher incidence of complica-
tions, longer hospital length of stay and increased mortality
in AKI patients (8). Nitrogen balance, which is a marker of the
extent of hypercatabolism and is the main nutritional
problem in these patients, also showed a significant associa-
tion with mortality in this population (9-10).
However, there are still few data available on the nutritional
status of this population or the existence of an association
between nutritional markers and important clinical outcomes.
The goals of this study were to compare the clinical,
laboratory and nutritional characteristics of surviving and
non-surviving AKI patients who were evaluated in a
Brazilian teaching hospital and to generate a hypothesis
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regarding the relationship between nutritional markers and
outcomes.
& METHODS
Ethics statement
The authors declare that this work was approved by the
research ethics committee of Botucatu School of Medicine
University Hospital. Participants provided their written
informed consent to participate in this study. The ethics
committee approved this consent procedure.
This was a prospective and observational study per-
formed from January 2009 to December 2011. A total of 133
patients with a clinical diagnosis of AKI and a clinical
presentation suggestive of acute tubular necrosis (ATN)
who were admitted to Botucatu School of Medicine
University Hospital, Sa˜o Paulo, Brazil were included.
Patients were required to have a minimum of 7 days of
follow up by the nephrology and nutrition team.
The diagnosis of AKI was based on serum creatinine
levels, as proposed by the Acute Kidney Injury Network
(AKIN) (1). Patients under 18 years old with AKI of other
etiologies, those requiring chronic renal replacement ther-
apy (dialysis or transplantation) and those with a history of
severe chronic kidney disease (baseline serum creatinine
.4 mg per 100 ml) were excluded. AKI patients were
followed prospectively from the day of the first nephrology
evaluation until nephrology discharge. The clinical char-
acteristics were recorded on the first day and the laboratory
and nutritional characteristics were recorded on the first
day and every 7 days during the hospital stay.
For the classification of CKD stage, the baseline serum
creatinine was defined as the lowest serum creatinine value
in the last 6 months before AKI or, for patients without this
measurement, the lowest value achieved during hospitali-
zation in the absence of dialysis. Patients with CKD were
considered to have stage 2 of the disease.
Nutritional assessment protocol
The Nutritional Assessment was based on the SGA
(Subjective Global Assessment), biochemical parameters,
anthropometry and bioelectrical impedance analysis (BIA)
and was performed daily or weekly from the first
nephrology evaluation until recovery of kidney function
or the patient’s death (8).
On the first day, clinical characteristics were measured
and an SGA was performed (9). Daily, blood urea nitrogen
(BUN), serum creatinine, and protein and energy intake
were measured, and the nitrogen balance (NB) was
calculated based on the excess of urea nitrogen appearance
(UNA) formula (3), as calculated below:
Nitrogen Balance = dietetic nitrogen intake – ureic
nitrogen appearance
Dietetic nitrogen (g/day) = dietetic protein (g/day)/6.25
Ureic nitrogen appearance (gN/day) = (UUN 6 V) +
(BUN2 – BUN1)60.66BW (kg) + (BW2–BW1)6BUN2/100
For patients on dialysis, nitrogen losses through the
dialysate were added to the UNA using the following formula:
Dialysate urea nitrogen (gN) x dialysate volume (l)
The rate of catabolism was calculated daily according to
the net protein breakdown (13):
UNA66.25/body weight (kg)
Anthropometry and BIA were performed once a week.
Ambulatory patients were weighed on a digital scale,
whereas the weight of non-ambulatory patients was
obtained using a bed scale. Arm circumference and triceps
skin-fold thickness (TST) were also evaluated. BIA was
performed using the single frequency equipment
Biodynamics model 450. It provided results including resis-
tance (ohms), reactance (ohms) and phase angle (˚). In
patients who were treated with hemodialysis, BIA was
performed 30 minutes after the end of the session.
Albumin (g/dl), transferrin (g/dl), prealbumin (g/dl), total
cholesterol (mg/dl), total lymphocyte count (mm/3), phos-
phorus (mg/dl), potassium (mmol/l) and C reactive protein
(CRP) serum levels (mg/dl) were measured once a week.
Statistical analysis
AKI patients were divided into two groups, survivors and
non-survivors, and the study variables were compared
between the groups. The results are presented as the mean
and s.d. or the median, according to normality characteristics
for each variable, with a 5% (p,0.05) significance level. The t-
test was used to compare parametric variables of clinical,
laboratory and nutritional data. For non-parametric vari-
ables, the Mann-Whitney test was used.
Statistical analyses were conducted using SAS
version 9.2 for Windows
Variables with significant univariate associations (p,0.20)
were candidates for the multivariable analysis. Multivariable
logistic regression was performed using stepwise variable
selection. Variables that were not selected by the automated
procedure were added back into the models individually to
evaluate them for residual confounding, and covariate and
propensity score adjustments were used to adjust for baseline
differences.
& RESULTS
A total of 133 AKI patients were followed and the mortality
rate of this group was 26.3%. Table 1 shows the baseline
clinical characteristics of the studied patients. Non-surviving
patients were older and exhibited more ICU admissions, a
higher prevalence of sepsis and more severe ATN-ISS. They
also showed a less favorable nutritional status based on a
subjective global assessment in the first assessment.
Based on the characterization of the CKD stages, 12% of
the patients were in stage 2, 6% were in stage 3A, 9.7% were
in stage 3B and 8.2% were in stage 4.
In tables 2 and 3, the results are shown according to the
baseline (first day) and the final assessment (last day for
each patient) and were compared between survivors and
non-survivors. The initial assessment was performed on day
1 and the final assessment was performed during the last
week (considering that the patients were evaluated at the
same time points: day 1, 7, 14, 21, 28…).
Table 2 shows the laboratory data of the survivors and
non-survivors. At the final assessment, non-survivors
showed significantly lower levels of albumin [(2.4 (2-2.9)
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vs. 2.0 (1.8-2.6), p= 0.04)], transferrin [(1.37(1.05-1.8) vs.
1.02(0.88-1.35), p= 0.009)], and cholesterol [(127.5 (102.8-
158.3) vs. 108 (86-139), p= 0.05)] compared with survivors.
Furthermore, all parameters were below normal values.
Lower levels of initial creatinine [(3.4 (2.5-4.85)64.3 (2.9-
6.25), p= 0.03)] and higher levels of BUN [(49.5(41.3-79.6) vs.
40.4(23.7-55.1), p= 0.002] and CRP [(7.2 (3.3-21.9) vs. 15.3
(5.9-27.7), p= 0.03)] at the final assessment were also
observed in the non-surviving patients.
Nutritional data are presented in table 3. Non-survivors
had higher measures of arm circumference (31.6¡6.21 vs.
29.3¡4.95, p= 0.03) at the final assessment, in addition to
higher estimated edema [(5(1-10.9) vs. 1.4(0-4.35), p= 0.002)].
Based on the BIA analysis, the non-survivors had lower
values of phase angle [(4.6(3.5-5.25) vs. 5.1(4.08-6.43),
p= 0.04)], resistance [(323¡105.6 vs. 410.9¡126.5, p= 0.002)],
and reactance [(19.4(17.5-34.6) vs. 40.1(24.5-53.3), p= 0.001)] at
the final assessment. Non-survivors presented lower calorie
(7.2(2.15-14.8) vs. 12.9(5.6-22.3), p= 0.01)] and protein intake
[(0.3(0.09-0.628) vs. 0.54(0.24-0.99), p= 0.02)] at the initial
assessment, as well as major catabolism, as shown by a more
negative nitrogen balance [(-3.56(-6.96 – 2.56) vs. -1.32(-2.84-
5.10), p= 0.004)].
A total of 22 factors met the criteria for inclusion in the
multivariable analysis, and in-hospital mortality was
significantly associated with older age (OR: 1.038, CI:
1.004-1.072, p= 0.02), the presence of sepsis (OR: 1.710, CI:
0.103-0.815, p= 0.02), and higher ATN-ISS (OR: 1.029,
CI: 1.007-1.052, p= 0.01). Increased levels of BUN (OR:
1.013, CI: 1.004-1.023, p= 0.005) and CRP (OR: 1.050, CI:
1.011-1.092, p= 0.01), initial lower caloric intake (OR: 0.950,
CI: 0.910-0.991, p= 0.02), higher levels of edema (OR: 1.138,
CI: 1.012-1.280, p= 0.03), increased resistance based on BIA
(OR: 0.995, CI: 0.991-1.000, p= 0.03), and a more negative
nitrogen balance (OR: 0.934, CI: 0.872-1.000, p= 0.04) were
also associated with an increased risk of death, as shown in
table 4.
Table 5 shows some of the criteria for a malnutrition
diagnosis proposed by the International Society of Renal
Nutrition and Metabolism (ISRNM). According to those
guidelines, only a cholesterol level ,100 mg/dl suggested a
trend toward worse nutritional status at the final assess-
ment.
A parallel analysis comparing all nutritional markers
according to the severity of the AKI (AKIN 1 and 2 vs. AKIN
3) showed that patients in the AKIN 3 group presented a
Table 1 - Clinical characteristics of the acute kidney injury patients according to survival.
Characteristics (%) Survivors (n = 98) Non-survivors (n = 35) p
Male 72.2 58.3 0.29
Age (years) 59¡16 67¡14 0.01
Hospital wards:
Clinics 68.4 68.6 0.85
Surgical 31.6 31.4
Admission in aICU 59.2 88.6 0.0031
Etiology of AKI:
Ischemic 48 54.3 0.65
Nephrotoxic 20.4 2.9 0.03
Mixed 31.6 42.8 0.32
bDM 21.4 20 0.94
Hypertension 37.7 42.8 0.74
Sepsis 21.4 57.1 0.0002
CKD 25.5 17.1 0.44
Oliguria 20.4 25.7 0.68
Initial serum creatinine (mg/dl) 4.3 (2.9-6.25) 3.4 (2.50-4.85) 0.03
Classification for AKI:
AKIN 1 10.2 11.4 0.91
AKIN 2 42,8 37,1 0,70
AKIN 3 43,9 45,7 0,99
Dialysis 53.1 71.4 0.09
Hemodialysis 36.7 54.3 0.11
Peritoneal Dialysis 16.3 17.1 0.91
dATN-ISS 0.41¡0.21 0.60¡0.22 ,0.0001
Days of hospitalization 26.3¡15.9 24.6¡11.2 0.97
Days of nephrologic and nutritional evaluation 13 (7-21) 14 (9-18) 0.52
Days of hospital stay before nutritional evaluation 6 (3-13) 9 (3.5-12) 0.95
Malnutrition by eSGA:
Well nourished (Class A) 47 20 0.0095
Moderately malnourished (Class B) 36.7 60 0.02
Severely malnourished (Class C) 16.3 20 0.81
Type of diet
Oral 45.9 17.1 0.0051
Enteral 45.9 60 0.22
Parenteral 8.2 22.9 0.04
a) ICU: intensive care unit.
b) DM: diabetes mellitus.
c) CKD: chronic kidney disease.
d) ATN-ISS: Acute Tubular Necrosis-Individual Severity Score.
e) SGA: Subjective Global Assessment.
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lower BMI, with median values of 25 kg/m2 (22-29.3) vs.
23.05 kg/m2 (21.75 -26.20, respectively), p= 0.021, and TSF
with values of 20 mm (14.6 -29.8) vs. 16.5 mm (11.1 -22),
p= 0.02. Therefore, we can conclude that the severity of the
AKI was associated with a reduction in body weight and
body fat.
Table 2 - Laboratory parameters at the initial and final assessments in the survivors and non-survivors.
Parameters Assessment Survivors Non-survivors p
BUNa (mg/dl) Initial 73.8¡30.50 77.8¡29.63 0.52
Final 40.4 (23.7-55.1) 49.5 (41.3- 79.6) 0.002
Creatinine (mg/dl) Initial 4.3 (2.9-6.25) 3.4 (2.50-4.85) 0.03
Final 2.1 (1.5-3.0) 2.6 (1.85-3.40) 0.06
Potassium (mmol/l) Initial 4.3 (3.9-4.97) 4.3 (3.8 - 5.25) 0.83
Final 4.0 (3.6-4.70) 4.0 (3.60-4.80) 0.57
Phosphorus (mg/dl) Initial 5.2 (4.12-6.37) 5.35 (3.97-6.47) 0.84
Final 3.75 (3.1-4.6) 4.35 (3.32-5.97) 0.04
Albumin (g/dl) Initial 2.4 (2.0 – 2.8) 2.3 (1.7 – 2.7) 0.64
Final 2.4 (2-2.9) 2.0 (1.8-2.6) 0.04
CRPb (mg/dl) Initial 8.8 (5.6-25.7) 16.2(5.7-30.0) 0.52
Final 7.2 (3.3-21.9) 15.3 (5.9-27.7) 0.03
TLCc (mm3) Initial 1126(855-1707) 1241 (737-1771) 0.93
Final 1340(987-1695) 912(673-1750) 0.11
Cholesterol (mg/dl) Initial 114.5 (84.7-153.5) 122 (85-146) 0.94
Final 127.5 (102.8-158.3) 108(86-139) 0.05
Transferrin (g/dl) Initial 1.35¡0.51 1.19¡0.65 0.08
Final 1.37 (1.05-1.8) 1.02 (0.88-1.35) 0.009
Prealbumin (g/dl) Initial 0.11 (0.08-0.14) 0.12 (0.06-0.19) 0.88
Final 0.16 (0.09-0.20) 0.16 (0.09-0.25) 0.41
a) BUN: blood urea nitrogen.
b) CRP: C-reactive protein.
c) TLC: Total lymphocyte count.
Table 3 - Nutritional parameters at the initial and final assessments in the survivors and non-survivors.
Parameters Assessment Survivors Non-survivors p
Dry weight (kg) Initial 70 (62-80) 73(62-80) 0.87
Final 69(58.6-76.5) 67(56.5-78) 0.96
BMIa (kg/m2) Initial 25.1(22.7-29) 24.4(22.5-28.2) 0.63
Final 24.2(21.9-27.6) 24(21.7-27.8) 0.76
ACb (cm) Initial 30.7(27.5-34) 31(27-34.5) 0.76
Final 29.3¡4.95 31.6¡6.21 0.03
TSFc (mm) Initial 22.8¡11.5 21.5¡9.11 0.6
Final 19.1¡9.51 20.5¡9.08 0.49
AMCd (cm) Initial 23.4¡2.59 23.1¡3.03 0.67
Final 22.7¡2.92 22.4¡2.76 0.63
Edema (l) Initial 3 (0-6) 3 (0-10) 0.37
Final 1.4 (0-4.35) 5 (1-10.9) 0.002
Phase Angle (o) Initial 5.2 (4.5-6.5) 4.75 (4.3-5.85) 0.21
Final 5.1(4.08-6.43) 4.6(3.5-5.25) 0.04
Resistance (ohms) Initial 323(264-444.1) 299.1(237.6-421.6) 0.44
Final 410.9¡126.5 323¡105.6 0.0023
Reactance (ohms) Initial 32.3(23.4-46.8) 26.2(20.1-38.7) 0.24
Final 40.1(24.5-53.3) 19.4(17.5-34.6) 0.001
Calorie (kcal/kg/day) Initial 12.9(5.6-22.3) 7.2(2.15-14.8) 0.01
Final 23.9(18-29.9) 25.6(9.39-28.6) 0.24
Protein (g/kg/day) Initial 0.54(0.24-0.99) 0.3(0.09-0.628) 0.02
Final 1.13(0.78-1.4) 1.15(0.59-1.48) 0.95
UNAe (gN/day) Initial 12.4(7.42-17.3) 12.6(6.55-23.3) 0.48
Final 10.2(6.51-14.8) 11.1 (6.29-18.8) 0.69
NBf (gN/day) Initial -6(-11.1-0.16) -3.76(-14.8-0.42) 0.47
Final -1.32(-2.84-5.10) -3.56(-6.96 - 2.56) 0.004
Protein catabolism rate (g/kg/day) Initial 0.99 (0.62-1.48) 1.37 (0.73-1.83) 0.16
Final 0.86 (0.56-1.35) 1.00 (0.57-1.58) 0.23
a) BMI: body mass index.
b) AC: arm circumference.
c) TSF: triceps skinfold.
d) AMC: arm muscle circumference.
e) UNA: urea nitrogen appearance.
f) NB: nitrogen balance.
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& DISCUSSION
This study shows that non-surviving patients had several
markers of nutritional status that were below normal and
that were significantly reduced compared with those of the
survivors. In addition, parameters such as caloric intake,
CRP, edema, resistance and nitrogen balance were inde-
pendently associated with an increased risk of death.
We also observed that the non-surviving population
exhibited a more severe clinical condition due to the longer
duration of ICU stay, and the higher prevalence of sepsis
and ATN-ISS.
The nutritional status of AKI patients is poorly described
in the literature. Fiaccadori et al. (8) assessed 309 patients
with AKI and identified the presence of malnutrition in 58%
of patients, based on the Subjective Global Assessment
(SGA). In our study, 60.2% of the patients exhibited
malnutrition (moderate or severe). Even with the subjectiv-
ity of the physical method of evaluation, the prevalence of
malnutrition was similar in both studies (11-12). Applying
SGA, Fiaccadori identified an association between severe
malnutrition and unfavorable prognosis (8). In this study,
non-survivors presented no significant differences in terms
of severe malnutrition but did show a higher incidence of
moderate malnutrition.
Laboratory evaluation is a tool used in several diseases to
monitor the metabolic response to nutritional support and
to identify the reserves of energy substrates (14).
Serum creatinine is used as a marker of muscle mass in
patients with chronic and acute kidney disease.
Paradoxically, some studies have shown that higher levels
of serum creatinine are associated with better survival of
AKI patients (15). In this study, non-survivors had lower
levels of creatinine in the first nutritional evaluation. The
hypotheses for this result include negative factors such as
the loss of muscle mass and hemodilution due to the
presence of edema, which indicated the poor prognosis.
Visceral proteins, which are conventionally used as
markers of nutritional status, are associated with mortality
in AKI patients. The reduction in the concentration of these
proteins may be associated with a decrease in their
synthesis, which can be a consequence of the limited supply
of energy and protein substrates commonly associated with
malnutrition (14).
Albumin is classically associated with nutritional status in
several diseases. Despite being influenced by hydration and
inflammatory status, its low levels indicate nutritional
impairment independent of such factors in AKI patients
(6-7). In this study, non-surviving patients had a median
albumin level of 2 g/dl, which is significantly lower than
that in surviving patients. However, the higher CRP levels
affected the application of albumin only as a nutritional
marker.
Prealbumin is also influenced by non-nutritional factors
such as inflammation, infection, liver diseases and changes
in hydration status, which may be involved in the reduction
of synthesis of this protein. In AKI patients, prealbumin
levels below 11 mg/dL were associated with a reduced
survival of approximately 45% at 90 days (4). In this study,
non-surviving patients showed prealbumin levels lower
than 0.11 g/dl throughout the assessment period. In our
study, all patients had elevated levels of CRP and lower
prealbumin levels (above 0.2 g/dl) during the assessment
period.
Table 4 - Multivariable analysis of the clinical, laboratory,
and nutritional parameters associated with death.
Multivariate analysis
Parameters Odds Ratio 95% CI p
Clinical
Age 1.038 1.004 – 1.072 0.02
Admission to ICUa 0.254 0.052 – 1.234 0.09
Ischemic AKIb 0.758 0.264 – 2.178 0.93
Nephrotoxic AKI 0.649 0.065 – 6.523 0.80
Sepsis 1.710 0.103 – 0.815 0.02
Dialysis 1.004 0.333 – 2.976 0.99
ATN-ISSc 1.029 1.007 – 1.052 0.01
Laboratory
BUNd 1.013 1.004 – 1.023 0.005
Creatinine 0.939 0.645 – 1.367 0.74
Phosphorus 1.260 0.901 – 1.763 0.17
Albumin 0.436 0.124 – 1.528 0.19
CRPe 1.050 1.011 – 1.092 0.013
TLCf 1.000 0.999 – 1.001 0.51
Cholesterol 1.005 0.997 – 1.013 0.19
Transferrin 0.611 0.143 – 2.614 0.50
Nutritional
Initial Calorie 0.950 0.910 – 0.991 0.02
ACg 0.961 0.850 – 1.086 0.52
Edema 1.138 1.012 – 1.280 0.03
Phase Angle 1.091 0.469 – 2.535 0.84
Resistance 0.995 0.991 – 1.000 0.04
Reactance 0.960 0.855 – 1.077 0.48
NBh 0.934 0.872 – 1.000 0.04
All laboratory and nutritional variables are from the final evaluation,
except calories.
a) ICU: intensive care unit.
b) AKI: acute kidney injury.
c) ATN-ISS: Acute Tubular Necrosis-Individual Severity Score.
d) BUN: blood urea nitrogen.
e) CRP: reactive protein.
f) TLC: Total lymphocyte count.
g) AC: arm circumference.
h) NB: nitrogen balance.
Table 5 - Prevalence of protein-energy wasting (PEW) (malnutrition) based on the International Society of Nutrition and
Renal Metabolism (ISRNM) diagnosis at the initial and final assessments.
PEW diagnosis Assessment Survivors (%) Non-survivors (%) p
Albumin ,3.8 g/dl Initial 96 97 0.784
Final 94.7 100 0.411
Cholesterol ,100 mg/dl Initial 32.6 37.5 0.775
Final 24.7 43.7 0.073
BMC ,23 kg/m2 Initial 29.3 24.2 0.737
Final 35 42.4 0.576
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Low levels of cholesterol have also been described as a
predictor of complications and mortality. In patients with
AKI, studies have shown that cholesterol levels have a
significant association with survival. Obialo et al. (6)
identified an approximately 50% reduction in survival in
AKI patients with cholesterol levels below 150 mg/dL at
admission. More recently, Guimara˜es et al. (7) studying 56
patients with AKI in the ICU showed that cholesterol levels
below 96 mg/dL were significantly and independently
associated with a reduced survival rate in these patients.
The findings of the present study also showed reduced
levels of cholesterol, especially in patients who died.
Transferrin is also affected by non-nutritional factors. In
the present study, non-survivors showed significantly lower
levels of transferrin at the final assessment, suggesting that
this marker may be associated with death in this population.
Based on the multivariable analysis, only CRP and BUN
were associated with death. Elevations in BUN can result
from increased catabolism of structural proteins, increased
amino acid turnover and negative NB (16). In the present
study, non-survivors presented higher levels of BUN at the
beginning of follow-up and such levels were associated with
a higher risk of death.
To date, no study has shown that CRP is a predictor of
mortality in AKI patients. Xie et al. reported that CRP is a
possible predictor of mortality in AKI patients. However,
based on the multivariate analysis, only the ratio of CRP/
prealbumin remained associated with mortality (17). In our
study, it was possible to show an association between CRP
and a higher risk of death based on the final assessment.
It is important to note that it was difficult to perform the
anthropometry measures on these patients. Given that 89%
of all of the patients were in the ICU, this difficulty becomes
more understandable. The lack of ambulation, decreased
level of consciousness and important presence of edema
were the main limiting factors. The main reason to
discourage the use of these methods is the lack of reliability
in the interpretation of the measurement results. It is known
that AKI is responsible for various situations that negatively
compromise the nutritional status of patients. Among these
are insulin resistance, increased secretion of catabolic
hormones, acidosis and the activation of catabolism and
the loss of nutrients by dialysis. Considering the large
number of causal factors that can exert a deleterious effect
on nutritional status, the lack of a difference between the
anthropometric parameters of the survivors and non-
survivors at the final assessment is unexpected. This result
suggests that, in fact, it is quite difficult to measure these
parameters in practice because of the reduced accuracy of
parameters such as weight, BMI, TSF and AMC in critically
ill AKI patients. Based on the multivariable analysis, there
was no association between anthropometric parameters and
mortality, confirming that these parameters have reduced
accuracy in critically ill AKI patients. Only edema was
associated with higher mortality, suggesting that this
clinical situation can significantly affect the use of anthro-
pometric parameters in AKI patients.
Unlike mortality, we observed that the severity of the AKI
according to AKIN classification was associated with loss of
body fat and body mass at the final assessment, as
evidenced by lower values of TSF and BMI, respectively.
These data suggest that patients with more aggressive AKI
may exhibit higher levels of nutritional impairment.
Therefore, the nutritional assessment could be interpreted
as a marker of AKI severity, which is associated with
outcomes. BIA is a non-invasive, easy and low-cost method
for body assessment. Its use in critically ill patients has
limitations because these patients experience frequent
changes in tissue hydration due to edema, ascites, serum
therapy and the use of diuretics (18). However, some BIA
parameters have been described as predictors of survival.
Given the lack of validation supporting the use of predictive
equations in acute situations, only independent parameters
from these formulas, such as resistance, reactance and phase
angle, were used in this study.
The phase angle, being a direct measure of the stability of
cells and being interpreted as an indicator of membrane
integrity and a predictor of body cell mass, has assumed an
important role as a prognostic indicator and predictor of
survival in different pathologies (19). A study involving
3009 patients receiving chronic hemodialysis showed that
phase angle values below 4.0 were associated with a
significantly higher risk of death after one year of follow
up (20). In the literature, there are no available data about
these parameters in patients with AKI. In this study,
patients who died had a median phase angle of 4.6,
suggesting that such lower values may be associated with
death in this population. These patients also showed
reduced levels of resistance (323¡ 105.6 ohms) and
reactance (median of 19.4 ohms) at the final assessment
compared with survivors, suggesting the presence of
unhealthy cell membranes and deficient integrity (21).
Despite not accurately indicating the composition of body
tissues, the parameters can be used as factors of poor
prognosis for this group of patients. Furthermore, this study
produced new data highlighting the protective effect of
higher levels of resistance, which were significantly and
independently associated with a lower risk of death.
When calories and protein supply were evaluated, both
survivors and non-survivors received quantities below
those recommended for hospitalized patients, critical or
not; 44.1 and 82.9% (data not shown) of survivors and non-
survivors, respectively, received enteral or parenteral nutri-
tion upon initial admission, such that the low supply and
slower progression is understandable and expected. Factors
such as prolonged fasting, abdominal distension and
absence of bowel, which are common in critically ill
patients, justify the small volume and decreased nutrients
of the initial diet administered to these patients. In this
study, prolongation of the offered diet was associated with
an increased risk of death.
Hypercatabolism is the main nutritional and metabolic
feature of AKI and is closely related to the increased
mortality in AKI patients. Factors such as insulin resistance,
increased secretion of catabolic hormones, inflammatory
response and nutrient loss through dialysis are among the
main causes. By calculating the urea nitrogen appearance,
it is possible to estimate the extent of protein catabolism
in AKI patients (3). Patients on continuous renal replace-
ment therapy present a rate of catabolism between 1.4 and
1.8 g/kg/day (22). In this study, there was no difference
between the urea nitrogen appearance and the protein
catabolism rate among survivors and non-survivors at any
point during the evaluation.
NB is a reliable method to assess nitrogen losses and to
classify the extent of catabolism. In this study, all patients
improved from the negative NB at baseline, advancing to
mild hypercatabolism during the course of the evaluation.
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At the end of the assessment, however, non-survivors still
had more negative NBs than did survivors.
NB has important associations with the clinical prognosis of
AKI patients. Scheinkestel et al. (9) evaluated the protein needs
of 50 critically ill AKI patients on continuous RRT and observed
that a positive nitrogen balance was significantly associated
with better prognosis in the ICU and hospital. In addition, each
1 g/day increase resulted in a 21% increase in the probability of
survival. High-volume peritoneal dialysis patients also showed
a significant association with survival. For each 1 g/day
increase in NB, there was a 31% reduction in the risk of death
in these patients (10). In the present study, a higher NB resulted
in a reduction of approximately 7% in the risk of death.
Diagnosing protein-energy wasting (PEW) in AKI
patients is difficult. However, the International Society of
Renal and Nutrition Metabolism (ISRNM) proposed the
utilization of several markers (23).
The authors selected some objective criteria, such as
albumin,3.8 g/dl, cholesterol,100 mg/dl, and body mass
index,23 kg/m2 (23). Only low cholesterol suggested a
trend toward a worse nutritional status at the final
assessment. Although recommended by the ISRNM, it is
important to emphasize the difficulty of relying on these
isolated criteria as markers of nutritional status.
This study has some limitations, such as the use of
nutritional parameters that are not very accurate but are
conventional, meaning they are easy and cost-effective to
implement. The reliability of SGA applied in critically ill
patients has been questioned; however, the same evaluator
performed the assessment, reducing the interobserver error.
A BIA single-frequency measurement was applied. Multi-
frequency BIA is indicated in critically ill patients, but that
approach also has limitations. Furthermore, this work did not
use parameters from the predictor equations. The evaluation
of the dry weight is subjective. It is likely that there was more
pronounced weight loss in these patients during the follow-
up period. However, it is quite difficult to precisely estimate
the correct weight due to the edema in this group of patients.
Despite the limitations outlined above, data from this study
show that through nutritional assessment of AKI patients
using laboratory methods, food intake, and catabolism, it was
possible to identify parameters associated with death.
A low calorie intake, higher CRP levels, the presence of
edema, a lower resistance based on bioelectrical impedance,
and a lower nitrogen balance were significantly associated
with a higher risk of death in AKI patients during the
assessment period. Easy and simple nutritional methods can
be applied in AKI patients and seem to identify markers
associated with outcome.
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